Current status of artificial intelligence analysis for the treatment of pancreaticobiliary diseases using endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography

Abstract

Pancreatic and biliary diseases encompass a range of conditions requiring accurate diagnosis for appropriate treatment strategies. This diagnosis relies heavily on imaging techniques like endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography. Artificial intelligence (AI), including machine learning and deep learning, is becoming integral in medical imaging and diagnostics, such as the detection of colorectal polyps. AI shows great potential in diagnosing pancreatobiliary diseases. Unlike machine learning, which requires feature extraction and selection, deep learning can utilize images directly as input. Accurate evaluation of AI performance is a complex task due to varied terminologies, evaluation methods, and development stages. Essential aspects of AI evaluation involve defining the AI's purpose, choosing appropriate gold standards, deciding on the validation phase, and selecting reliable validation methods. AI, particularly deep learning, is increasingly employed in endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography diagnostics, achieving high accuracy levels in detecting and classifying various pancreatobiliary diseases. The AI often performs better than doctors, even in tasks like differentiating benign from malignant pancreatic tumors, cysts, and subepithelial lesions, identifying gallbladder lesions, assessing endoscopic retrograde cholangiopancreatography difficulty, and evaluating the biliary strictures. The potential for AI in diagnosing pancreatobiliary diseases, especially where other modalities have limitations, is considerable. However, a crucial constraint is the need for extensive, high‐quality annotated data for AI training. Future advances in AI, such as large language models, promise further applications in the medical field.

Advances and efficacy in specimen handling for endoscopic ultrasound‐guided fine needle aspiration and biopsy: A comprehensive review

“…Specifically, the application of AI in EUS, EUS-FNA, and EUS-FNB has primarily been investigated in the context of differential diagnoses or analyses based on EUS imagery. [20][21][22][23] However, the potential of AI in the processing of pathological specimens obtained by EUS-FNA remains largely unexplored. In the study conducted by Lin et al 24 evaluating AI-assisted ROSE, a total of 467 digitized images of Diff -Quik stained EUS-FNA slides were segmented into training (3642 tiles from 367 images) and internal validation sets (916 tiles from 100 images).…”

The Applications of Artificial Intelligence for Assessing Fall Risk: Systematic Review

“…In the health care field, artificial intelligence (AI) is characterized by data management and processing, offering new possibilities to the health care paradigm [ 24 ]. Some applications of AI in the health care domain include assessing tumor interaction processes [ 25 ], serving as a tool for image-based diagnostics [ 26 , 27 ], participating in virus detection [ 28 ], and, most importantly, as a statistical and predictive method [ 29 - 32 ].…”